Yestar Healthcare Holdings Company Limited (Yestar Health) reported no changes to either its authorised or issued share capital for the month ended 30 June 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 2 July 2026.

Authorised capital remained at 4.00 billion ordinary shares with a par value of HKD 0.025 each, equivalent to HKD 100.00 million. Issued share count was unchanged at 2.33 billion shares; no treasury shares were held or cancelled during the period.

The company confirmed compliance with the Main Board’s minimum public-float threshold of 25% as at month-end. No share options, warrants, convertible instruments, or other equity-linked agreements were outstanding or exercised, and no new shares were issued under any arrangement during the month.

Director Qiao Jinrong submitted the statement, affirming that all regulatory and statutory requirements related to the company’s securities remain fully satisfied.